Posit Science

Posit Science is a San Francisco-based neurotechnology company specializing in cognitive health through its flagship platform, BrainHQ. The company develops a comprehensive suite of evidence-based brain training exercises designed to target core cognitive domains including processing speed, memory, and attention. BrainHQ is built on decades of neuroscience research and uses adaptive algorithms to personalize training intensity and difficulty based on individual performance. The platform is delivered digitally, making it accessible to a broad range of end users across consumer, clinical, and enterprise settings.

Posit Science has established a strong market position within the cognitive health space, supported by a body of clinical evidence that distinguishes it from many competitors. BrainHQ has been validated in over 100 peer-reviewed studies, lending it a level of scientific credibility that is relatively rare among consumer-facing brain training products. The company has secured partnerships with healthcare systems and employers, expanding its reach beyond individual consumers into institutional and workplace wellness markets. Having raised $18 million in Series B funding, Posit Science has demonstrated meaningful investor confidence in its science-driven approach to cognitive improvement.

Posit Science represents an important case study in how rigorous clinical validation can serve as a durable competitive advantage in the neurotechnology industry. As cognitive decline, workplace productivity, and aging population health become increasingly pressing priorities for both healthcare systems and employers, demand for evidence-backed cognitive interventions is growing substantially. The company's ability to bridge consumer accessibility with clinical credibility positions it as a meaningful contributor to the broader conversation around brain health as a measurable and improvable biomarker. Its work continues to push the industry toward higher standards of scientific accountability and outcomes-driven product development.